A prospective natural history study of inclusion body myositis: Implications for clinical trials

Neurology

Volumn 57, Issue 3, 2001, Pages 548-550

  Rose, M R ^a   McDermott, M P ^b   Thornton, C A ^b   Palenski, C ^b   Martens, W B ^b   Griggs, R C ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; LEAN BODY WEIGHT; MALE; MUSCLE MASS; MUSCLE STRENGTH; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RELIABILITY;

EID: 0035859951     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.3.548     Document Type: Article

References (10)

1. Inclusion body myositis and myopathies
2. Facioscapulohumeral dystrophy natural history study: Standardization of testing procedures and reliability of measurements
3. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): Implications for therapeutic trials
4. The assessment of muscle mass in progressive neuromuscular disease
5. Estimation of total body fat from potassium-40 content
6. Inclusion body myositis. Observations in 40 patients
7. Inclusion body myositis: Clinical, morphological, physiological and laboratory findings in 18 cases
8. Disease progression in sporadic inclusion body myositis: Observations in 78 patients
9. The treatment of inclusion body myositis: A retrospective review and a randomised prospective trial of immunosuppressive therapy
10. Evaluation of treatment for sporadic inclusion body myositis